ArticleBMC complementary medicine and therapies2025

Leonurine (SCM-198) exerts protective effects on pancreatic β-cells in type 1 diabetes by modulating the Bax/Bcl-2/Caspase-3 signaling pathway.

Zhiqi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.